ANDA 83383, held by Wyeth Ayerst. Hydroflumethiazide.
As of Nov 16, 2026, ANDA 83383 (Diucardin), held by Wyeth Ayerst, was first approved by FDA on Dec 20, 1973, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diucardin50MG ยท tablet;oral | Hydroflumethiazide | Discontinued |
| Dec 28, 1990 | Supplement 14Labeling | Approved | None posted |
| Dec 28, 1990 | Supplement 13Labeling | Approved | None posted |
| Jan 18, 1989 | Supplement 12Labeling | Approved | None posted |
| Dec 28, 1987 | Supplement 11Manufacturing | Approved | None posted |
| Jul 12, 1982 | Supplement 9Manufacturing | Approved | None posted |
| Dec 20, 1973 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters